Monograph
J07CA06 - Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus |
Propably not porphyrinogenic |
PNP |
Rationale
Based on the pharmacokinetics of the diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus vaccine (DTP-IPV-Hib), there are no conceivable porphyrinogenic effects.
Chemical description
Diphtheria Toxoid, Tetanus Toxoid, Pertussis Toxoid, inactivated poliovirus (type 1,2 and 3) and Haemophilus influenzae Type b Polysaccharide (DTP-IPV-Hib)
Therapeutic characteristics
The DTP-IPV-Hib vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type B disease from the age of 2 months. It is administered by intramuscular injections according to a three or four dose schedule.
Metabolism and pharmacokinetics
The DTP-IPV-Hib vaccine is not metabolized by the cytochrome P450 system.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Government bodies | |
| 1. | Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015).
|
|
| * | Summary of Product Characteristics | |
| 2. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). INFANRIX-IPV+Hib. (Last edition: 19.02. 2015).
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Infanrix IPV + Hib · Pentavac 
Infanrix-ipv+hib · Pentavac 
Infanrix-IPV + Hib · Pediacel vaccine 
Infanrix-Polio+Hib · Pentavac 
Infanrix - IPV + Hib 
Infanrix-ipv+hib · Pentavac 
Pentavac 
Infanrix-Polio+Hib · Pentavac 
Pentaxim 
Infanrix · Pentaxim
© NAPOS 2025